A meta-analysis conducted by Xu et al. found that homozygous mutations of CYP1B1*2 G355T and CYP1B1*3 C4326G may be low penetrance risk factors for lung cancer occurrence [16], which is consistent with results reported by Chen et al. [17]. The gene discussed is CYP1B1; the disease is lung cancer.